BioCentury
ARTICLE | Company News

Affymetrix, Thermo Fisher deal

January 18, 2016 8:00 AM UTC

Thermo Fisher will acquire cellular and genetic analysis tools company Affymetrix for $14 per share in cash, or about $1.3 billion. The price is a 52% premium to Affymetrix’s close of $9.21 on Jan. 8,...